PSMA PET Beats MRI in Prostate Cancer Staging Study

Published Date: 05 Jul 2024

Findings support PSMA PET in the preoperative workflow of intermediate- and high-risk tumors

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Do I qualify for a cancer clinical trial?

2.

DNA origami offers more accurate imaging in the fight against pancreatic cancer

3.

According to a study, there is now a 94 percent survival rate for children with acute lymphatic leukemia.

4.

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

5.

Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot